GNAS and pancreatic intraductal papillary-mucinous neoplasm: These findings reinforce the relevance of NRF2 loss to human IPMN pathophysiology and suggest that NRF2 modulates distinct molecular pathways that drive lineage-specific pancreatic tumorigenesis independently of GNAS activation.